# An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

> **NCT01447446** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 4442 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Peg-IFN Alfa-2a
- **DRUG:** Peg-IFN Alfa-2b
- **DRUG:** Ribavirin
- **DRUG:** Boceprevir
- **DRUG:** Telaprevir

## Key facts

- **NCT ID:** NCT01447446
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 4442 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447446, "An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01447446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*